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Recent  investigations  have  indicated  that  one  way  in  which  to  achieve 
selectively toxic antimetabolites is to  find a  biological precursor of a  vitamin, 
and then to construct a suitable analog of it. Such an  analog may then harm 
those species which synthesize this vitamin, and should not affect those which 
have a  nutritional requirement for it.  Thus,  the selective toxicity of sulfanil- 
amide  and  its  congeners for  certain  bacteria  in  contrast  to  higher animals 
has  been  postulated  to reside in  the difference in requirement for folic acid 
(1-3). This postulate has received support in the finding that the harmful  ac- 
tion  of  a  pimelic  acid  analog  could  be  foretold  with fair precision from a 
knowledge of nutritional requirements for biotin (4). The vitamin which arises 
from the precursor by a series of biosynthetic reactions (e.g., biotin) sometimes 
may be able completely and non-competitively to erase the effects of the analog. 
The  present  investigation  was  undertaken  with  two  questions  in  mind. 
(a)  Could additional  substances  of predictable  selective  toxicity be  realized 
by  construction  of  structural  analogs  of  a  precursor  of  another  vitamin? 
(b)  Could a means be found to foretell antimetabolites of the precursor which 
would not be counteracted by the vitamin? 
With regard to the first question, the correlation of the selective toxicity of 
sulfanilamide and  of  the pimelic acid  analog  with  nutritional  requirements 
for the vitamins,  folic acid or biotin, was just cited. In  the present study a 
single precursor of both riboflavin and vitamin B~2 was sought,  an  analog of 
this precursor was prepared, and it has been shown to retard the growth of all 
species examined except those with a  nutritional need for these two vitamins. 
This demonstration added  evidence in favor of the postulate that  selectively 
toxic substances can be achieved in this general way. 
The bearing of the second question on some of the problems of chemotherapy 
and of pharmacology can  be seen from consideration of  the  action  of  sulfa- 
nilamide,  in contrast to that of the pimelic acid analog mentioned above. This 
* Results of this investigation were described before the VII International Congress for 
Cell Biology,  New Haven, September 4, 1950. 
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latter  antimetabolite  retarded  the  growth  of biotin-synthesizing organisms, 
and this action was overcome competitively  by pimelic acid (4). Such organisms 
have been shown probably to carry out the formation of biotin by a  series of 
reactions starting with pimelic acid  (5,  6).  The growth retardation is  there- 
fore probably due to an interference with this synthesis. In accord with this 
opinion it was found that if biotin was present in the culture fluid, the pimelic 
acid analog was no longer toxic. Similarly, those species which lacked the ability 
to synthesize biotin, and depended on their food for it, were not susceptible to 
the toxicity of the analog. 
Nevertheless, the ability to counteract the analog with the vitamin related 
to it further up the biosynthetic pathway probably  accounts in part for the 
failure of such compounds as therapeutic agents in infectious diseases. In such 
chemotherapy it is necessary to retard one species selectively when it is growing 
in mixed culture with another  (i.e.,  the host  animal). This is a  considerably 
more exacting task than is the selective inhibition of isolated species.  In terms 
of the example with the pimelic acid analog, biotin-independent forms can be 
affected, and  biotin-dependent  ones  are  not  when  tested  singly.  However, 
when tested in mixed culture, the biotin needed to secure any growth of the 
latter forms negates the action of the analog on the former ones. As a  result, 
neither is harmed. This has proved to be true experimentally. Thus, although 
mice were resistant to this pimelic acid analog, and tubercle bacilli were quite 
susceptible, it was found incapable of saving mice from mortal infection with 
tubercle bacilli (7). The biotin within the animals probably nullified the anti- 
bacterial power of the compound. Of course, this explanation is not the only 
one which may apply, but it seems the most plausible one in view of existing 
knowledge. 
The chemotherapeutic action of sulfanilamide indicates the probable point 
of difference of a  successful drug from one which  is not so. This analog of 
p-aminobenzoic acid would be expected to be counteracted by folic acid, the 
product somewhat further up the biosynthetic path. However, in practically 
all cases this is not found to be the case. Only in the case of a  few species of 
enteric streptococci will folic acid nullify the antibacterial  action of  the sul- 
fonamide drugs (2,  8). These organisms are among those which are resistant 
to  sulfonamide therapy when they invade animal tissues.  Perhaps  the  folic 
acid in these tissues accounts for the failure of the drugs to act. When grown 
in isolated culture in the absence of excess  folic acid, the enteric streptococci 
are susceptible to sulfanilamide  (2). The chemotherapeutic successor sulfonamide 
drugs thus may depend on an inability of folic acid to erase its antibacterial 
powers, just as the chemotherapeutic failure of the pimelic acid analog may be 
related to the ability of biotin to do so. The problem then is to understand the 
basis of this difference, or failing that, to comprehend enough of it to provide 
conditions favorable to  the  formation of similarly irreversible  agents which 
will act in mixed cultures. D.  W.  WOOLL~'¢  15 
The  working  hypothesis which  has  been  explored  in  this  study is  that 
selectively acting  compounds  which  are  not  nullified by  vitamins  further 
along the biosynthetic path, can be made by choice of a  metabolic precursor 
of two  or more vitamins and production of a  suitable analog of this precursor. 
The desirable type of action of sulfanilamide is believed to  reside in such a 
situation. It is an analog of p-aminobenzoic acid, which is a precursor  of folic 
acid,  and possibly of some  other  essential  metabolite as  well.  These  other 
essential metabolites are  not considered to be the purines,  serine,  or valine 
(9), because, although the latter influence the action of sulfanilamide, the bulk 
of evidence points to the conclusion that they are  products arising from re- 
actions of folic acid,  and hence  only secondarily from p-aminobenzoic acid. 
(See  for example references 10-12.)  It is not  possible  to give any well docu- 
mented reason why an analog of a precursor of two or more vitamins should 
act in the desired irreversible fashion. One might expect a mixture of these two 
or more metabolites to erase the effect just as biotin does for the pimelic acid 
analog. Although to support  the postulate an argument can  be  constructed 
which is based on competing rates of reaction for the precursor and on differ- 
ences in  the way the  two vitamins are metabolized, sufficient data are  not 
available to make it definitive. 
The working hypothesis can b~ tested in the following way. A precursor of 
two or more vitamins should be sought, and an antimetabolite of it should be 
made. This antimetabolite ought then to prove harmful to species which do 
not have a nutritional need for both of these vitamins, and harmless to those 
which require them. Furthermore,  both vitamins should be  unable to nullify 
the toxic effect of the analog, while the precursor to which it is structurally 
related should do so competitively. 
1,2-Dimethyl-4,5-diaminobenzene was  recognized as a  probable precursor 
of riboflavin and of vitamin BI~, and some evidence for this opinion was found. 
This diamine occurs in riboflavin fused to a pyrimidine ring and a ribityl side 
chain.  It  has  also  been  identified  in  vitamin  BI~  as  part  of  a  dimethyl- 
benzimidazole riboside which occurs in acid hydrolysates of the vitamin (13). 
An antimetabolite of it, namely 1,2-dichloro-4,5-diaminobenzene showed those 
biological properties expected of such an analog. 
EXPER  IArl~NTAL 
1,2-Diehloro-4,5-diaminobenzene.--This substance seems to have been obtained previously 
only as an impure oil of unestablished constitution 04). It can be prepared readily as a pure 
substance in either of the following ways. 
Eighteen gin. of 1,2-dichloro-4,  5-dinitrobenzene (15) was suspended in 120 cc. of concen- 
trated HCI,  the mixture was heated on a  steam bath, and 30 gin. of mossy fin was added 
slowly. The mixture was shaken vigorously during the addition of the tin, and the flask was 
equipped with an air condenser during the operation. When the order of addition was changed, 
the product was black, and difficult to purify. The mixture was heated for half an hour on the 
steam bath after all the tin had been introduced, and then 200 cc. of water and about 3 gin. 16  SELECTIVE  TOXICITY 
of norit were added. The mixture was filtered while it was still hot, and the colorless filtrate 
was  concentrated  under  reduced  pressure  until extensive crystallization had  occurred  (to 
about 100  cc.). The mixture was cooled and saturated with HCI gas and the crystals were 
collected, washed with concentrated HCI, and recrystallized from 50 cc. of water by saturating 
the solution with HC1. The yield was 13.4 gin. of white needles. When heated on a microscope 
stage the shape of the crystals changed at about 155  ° from needles to plates, and these melted 
with decomposition at 193  °. These values were unchanged by recrystallization. 
CsH~N~CI4. Calculated, N  11.2; found, N  11.3 
A substance with the same characteristics was formed when 1,2-dichloro-4-amino-5-nitro- 
benzene was similarly reduced with tin and HC1. The starting material for both routes was 
1,2-dichloro-4-nitrobenzene. The  direct nitration required  in  the first method  limited  the 
scale of the operations, but the over-all yield was better than by the second procedure. 
The free base was  obtained by solution of the dihydrochloride in water,  addition of an 
excess of 1 ~ NaOH, and extraction with ether. Evaporation of the ether from the extract left 
white or pink crystals which were purified by recrystallization from hot water. These crystals 
began to shrink at about 130  ° and slowly changed as the temperature was raised, until they 
had disappeared at about 160  ° . 
CsHgNT2C12. Calculated, C 40.7,  H  3.4, N  15.8 
Found,  C 40.9,  H  3.4,  N  16.0 
Sources of the Organisms Used.--Cultures  of Lactobacillus leichmanni  313 were obtained 
from Dr. V. du Vigneaud and from Dr. L. D. Wright, who also supplied L. lactis (Dorner) and 
L.  bifidis. Euglena gracilis was  from  Dr.  S.  H.  Hutner.  Chlordla mdgaris and  the 6  plant 
pathogens, Pseudomonas tabaci, P. angulata, Corynebacterium mivhiganense, C. fascians,  Agro- 
bacterium tumefaciens, and Xanthomonas  pdargonl  were provided by Dr.  A.  C.  Braun. L. 
brevis was from Dr. M. S. Dunn, and Ophiostoma multiannulatum  from Dr. N. Fries. Shigdla 
sonnei was  supplied  by Dr.  W.  F.  Goebel,  Salmonella  typhimurium  was  from  Dr. H.  A. 
Schneider and Proteus and Bacillus tenuis were from Dr. R. J. Dubos.  The assistance of these 
donors is gratefully acknowledged. All other species were those used in this  laboratory for 
several years. 
Manner of Testing Effect of Analog on Growth of Microorganisms.--A  culture medium ade- 
quate for the growth of the species under observation was distributed in 10 cc. portions in 
test tubes, and sterilized at 120  °. Neutralized, aqueous solutions of the dichlorodiaminoben- 
zene dihydrochloride were sterilized separately, and added aseptically just before inoculation. 
Sufficient water was omitted from the tubes in a series to allow for this addition. The heating 
of any phenylenediamine derivative in the basal media was avoided. The cells from a young 
broth culture of the organism were washed once, and diluted to 1/100 of their original con- 
centration, and 1 drop was used to inoculate each tube. Incubation at the temperature best 
suited  to each species was continued until maximal growth was observed in the unsupple- 
mented basal medium. Prolonged incubation invariably made the diamine appear less toxic. 
The amount of growth was determined by measurement of turbidity in an Evelyn colorimeter, 
and in addition, where this could be done, by titration of the acid produced.  Dose-response 
curves were constructed, and from them the amount of substance which allowed half-maximal 
growth was estimated. 
The basal medium employed for nearly all species was that of Landy and Dicken (16)  in 
which folic acid was supplied as pteroyl glutamic acid (0.01 "y per co.), and in which riboflavin 
was present in 0.1 ,/per cc. An effort was made to use the same basal medium for all species 
in order  to eliminate the chance of differences in toxicity arising from dissimilarities of the 
culture fluid. However, for a few of the species special media were necessary to secure growth. 
For O. multlannulatum  the one described by Fries et al. (17) was used, and for Saccharomyces 
cereviseae, one developed earlier (18)  was employed. Because P. tabaci and P. angulata failed 
to grow in the enriched medium of Landy and Dicken, tests with these organisms were done D,  w.  WOOLLEY  17 
in the mixture of glucose and salts proposed by Hook a d. (19). For L. lactis (Dorner) and L. 
le/chmanni a  tryptic  digest of casein (0.5 mg. per cc.) and crystalline vitamin Bl2 (0.003 ~, 
per cc.)  1  were added to the Landy-Dicken medium as recommended by Hoffmann e/at. (20). 
This was done in preference to use of the solution proposed by these authors, because the 
concentration of heavy-metal salts which they employed was great enough to cause darkening 
and precipitation of the dichlorodiaminobenzene.  In order to induce L. bifMis to grow in this 
medium, the increased vitamin levels used by Skeggs a d. (21) were employed. The effects of 
such additions to the medium of Landy and Dicken, on the toxicity of the analog for Staphy- 
loceccus aureus, and for L. case/and for E. coli were found to be negligible  in comparative trials. 
Therefore, these alterations did not seem to be of great importance for the values observed. 
Similarly, vitamin BI~ did not influence the toxicity for any species except the two to be dis- 
cussed below. Those organisms which did not require the presence of riboflavin were tested 
with the analog in the absence of this vitamin as well as with 0.1 3' of it per cc., but the  re- 
suits were comparable. E. gracilis and C. vulgarls were grown in the medium described by 
Hutner et al. (22). The requirements of each species for riboflavin and for vitamin B12 were 
determined in these media by omission of one or the other and observation of growth re- 
sponse in comparison to a supplemented control in the usual fashion. 
TABLE I 
Growth-Inhibitory Effect of 1,2-Dictdoro-4,5-diaminobenzene Dihydrochloride on 
Staphylococcus aureus 
Analog  Light transmission  by the culture 
#er co.  #~r cent 
0  65 
3  70 
10  96 
Inhibition  of Growth  of Staphylococcus  aureus  by 1,2-Dichloro-4,5-Diamino- 
bemene.--The  data in Table I  illustrate the effect of the analog on the growth 
of S. aureus when the test was conducted in the manner just indicated. Half- 
maximal inhibition was achieved with 6 3" per cc. In a  series of similar trials, 
the value varied from 5 to 10 3/depending somewhat on the time of incubation. 
Selective  Toxicity  of  1,2-Dichloro-4,5-diaminobemene  Correlated  with  Nu- 
tritional  Requirements  for  Riboflavin  and  Vitamin  Bl~.--When a  number of 
microbial species were examined in the manner just indicated, the toxicity of 
the analog for each was found to be as shown in Table II. The requirements 
for riboflavin and for vitamin B12 were also observed to be as indicated there, 
and these were in close agreement with existing knowledge about such needs. 
The  maximal  concentration of  the  dichlorodiaminobenzene dihydrochloride 
which could be tested was 300 3' per cc., because with larger amounts a  precipi- 
tate formed during the incubation period. 
Those species which required both vitamins were insusceptible to the growth- 
1 Crystalline vitamin Bl~ was very generously supplied by Drs.  E. L.  R.  Stokstad  and 
T. H. Jukes of Lederle Laboratories; and by E. R. Squibb and Sons, Inc. 18  SELECTIVE TOXICITY 
inhibiting  action of the analog, while those which needed neither vitamin were 
usually  quite  susceptible.  The  Gram-negative  enteric  bacilli  (E.  coli,  S. 
TABLE II 
Toxicity  of  1,2-Dichloro-4,54iaminobenzen~  Correlated  wi~h  Nutritional  Requirement~  for 
Riboflavin and Vitamin B~ 
Toxicity is expressed as amount of the dihydrochloride which caused half-maximal in- 
hibition of growth in a synthetic medium containing all known nutrients. 
Organism 
Lactobacitlus bre~is ............ 
Lactobacillus arablnosus ....... 
So,~charorayces  cereviseae ...... 
Staphylococcus aureus ......... 
Streptococcus recalls R ......... 
Bacillus tenuls ............... 
ChlorelIa vulgarls ............. 
Ophiostoma  multiannulatum 
mutant strain 1671  ......... 
Leuconostoc mesenteroides ...... 
Xanthomonas pdargoni ....... 
Corynebacterium fascians ...... 
Corynebaeterium michiganense. 
Pseudomonas angulata ........ 
Pseudomona~ tabaci .......... 
A grobacterium tumefaciens ..... 
Escherichia coli .............. 
Proteus strain 4 .............. 
Shigdla sonnei ............... 
Salmonella typhlmurium ...... 
Lactobozillus easel ............ 
Hemolytic streptococcus H69D. 
Euglena gracilis ............... 
Lactobacillus  leichmanni  strain 
313 ....................... 
Lactobacillus  bifutis strain 4963. 
Lactobo, cillus  lactis  (Dorner) 
strain 8000 ................  i 
I  Temper- 
i atureof  TI 
i incuba- 
,  tion 
°¢. 
30 
30 
30 
37 
30 
37 
25 
30 
30 
25 
25 
25 
25 
25 
25 
37 
37 
37 
37 
37 
37 
25 
37 
37 
37 
ae of I 
uba-  I 
ion 
,,-2- 
2 
1 
t 
1 
1 
1 
Amount  of 
analog 
-t per co. 
6 
10 
6 
6 
40 
20 
10 
20 
4 
1 
l 
0.6 
100 
30 
60 
200 
t00 
200 
100 
140 
180 
100 
No effect at 
300* 
Riboflavin 
requirement 
None 
C~ 
C¢ 
~c 
~c 
¢c 
4c 
4c 
c~ 
cc 
cc 
Required 
gc 
None 
Required 
Vitamin  BI~ 
requirement 
None 
~c 
c¢ 
c~ 
c~ 
c~ 
c~ 
~c 
~c 
¢¢ 
L¢ 
Required 
* This was the largest concentration which could be dissolved in test media. 
typhimurium,  S.  sonnei,  and Proteus)  were  considerably more resistant than 
other forms which showed no nutritional need for riboflavin and vitamin Bt~. 
This was noteworthy in view of a  somewhat similar situation with respect to 
the  comparative resistance  of  such  species to  sulfanilamide. The organisms D.  W.  WOOI2.EY  19 
which required only one of the two vitamins preformed in the medium tended 
to be more resistant  than closely related species which required neither, but 
they were still affected by the analog when present in sufficient concentration. 
Thus L. casei was somewhat more resistant than L. arabinosus, and E. gracilis 
was more so than C.  vulgaris.  However, the number of such species was not 
large enough to warrant a sound conclusion on this point. 
The  correlation of  susceptibility  and  nutritional  need  for riboflavin  and 
vitamin  B19 appeared  to best  advantage  when the different lactobacilli were 
compared.  Among  this group  of physiologically and  morphologically related 
species those which showed the nutritional requirements were quite resistant, 
while those which did not were among the most susceptible. 
Tolerance  of  Mice  for  1,2-Dichloro-4,5-diaminobenzene.--This  compound 
was relatively non-toxic to mice.  For these tests Swiss strain albino animals 
ranging in age from 4  to  12 weeks were usually employed, but other strains 
were also tested with entirely similar results. All animals were fed a stock ration 
(purina fox chow). Eleven individuals injected daily with an aqueous solution 
of 10 rag. of the dihydrochloride for 10 days showed no detectable sign of injury. 
Sixteen animals  responded similarly when  the dihydrochloride was  made  to 
constitute 0.5 per cent of the food, and in addition, were injected daily intra- 
peritoneally with 6 rag. of the free base dissolved in olive oil. This combined 
treatment was continued for 1 month, during which  time the animals gained 
weight. 
Competitive  Antagonism  of  the  Action  of  the  Dichlorodiaminobenzene  with 
1,2-Dimethyl-4 ,Y-diaminobenzene  in Bacteria.--The  growth-inhibiting proper- 
ties of the dichloro compound were antagonized, and in a  competitive fashion, 
by 1,2-dimethyl-4,5-diaminobenzene,  ~ the postulated metabolic precursor to 
which the halogenated analog was structurally related. The data in Table III 
illustrate this point in the case of S. aureus. A similar situation was found with 
each  one  of  the  susceptible  species,  except with  the  Gram-negative enteric 
bacilli, which were not tested in this way. 
The  concentration of dimethyldiaminobenzene required  to  antagonize  the 
action  of the dichloro analog was  somewhat  greater than  that  which  might 
be expected if the former were a  true metabolic precursor of the 2  vitamins 
under consideration. Thus,  to antagonize a  minimally inhibitory amount of 
the dichloro compound in S. aureus about 1 3, of the dimethyldiaminobenzene 
per  cc.  was  demanded.  By  analogy  with  the  sulfanilamide-p-aminobenzoie 
acid case, one would expect considerably less to be effective. Furthermore the 
dimethyldiaminobenzene was itself toxic in all species tested when sufficiently 
high concentrations were employed. Thus, 200 3, per cc. caused half-maximal 
inhibition of the growth of S. aureus. This toxicity may be reminiscent of the 
antimicrobial effect exerted by high concentrations of p-aminobenzoic acid. 
2  A sample of this compound was generously  supplied by Dr. R. B. Pringle of these lab- 
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Antagonism  of the Action of 1,2-Dichloro-4,5-diaminobenzene  with o-Phenyl- 
enediamine.--In  the  case  of  S.  aureus,  the  growth-inhibiting  action  of  the 
dichloro compound  was  overcome by  o-phenylenediamine.  The  latter  com- 
pound was considerably less active than was 1,2-dimethyl4,5-diaminobenzene, 
TABLE III 
Competitive Antagonism of 1,g-Dimethyl-4,5-diaminobenzene Dihydrochloride and 
1,2-Dichloro-4 ,5-diaminobenzene Dihydrochloride to the Growth 
of Staphylococcus aureus 
Dimethyldiarninobenzen¢  Dichlorodiaminobenzcne  needed  Additional  dichloro  analog 
added  for half-maximal inhibition  needed* 
*'It ~cr  CO. 
0 
1 
3 
9 
27 
8 
11 
2O 
30 
69 
-)'  ~er  cc. 
3 
12 
22 
61 
* This is the amount necessary  to antagonize the dimethyldiamine added to the medium 
and is column  2 minus the amount of dichloro  analog found necessary  with no added di- 
methyl compound. 
A ntagonism 
TABLE IV 
between o-Phenylenediamine and  1,2-Dichloro-4  ,5-diaminobenzene 
Dihydrochloride in the Growth of Staphylococcus aurcus 
o-Phenylenediarnlne  Dichlorodiaminobenzene  Light transmission by the culture 
0 
0 
0 
IO0 
30 
20 
2O 
10 
10 
0 
10 
3 
0 
0 
0 
10 
10 
3 
69 
95 
80 
100 
82 
71 
74 
81 
73 
but 20 3"  of it per cc.  overcame almost completely the effect of  10 3'  of  the 
dichloro compound per cc.  Data to illustrate this antagonism are contained in 
Table IV. Because o-phenylenediamine was itself toxic above 20 3" per cc.  no 
more extensive study of its apparently competitive behavior could be made. 
Activity  of  1,2-Dimethyl-4 ,5-diaminobenzene  in  Replacement  of  Riboflavin 
and  Vitamin  Bx2.--The  dimethyldiaminobenzene  exhibited  some  slight  ac- 
tivity as riboflavin when  tested with L.  casei,  and some potency as vitamin D,  W.  WOOLLEY  21 
BI~ for L.  leicttmanni,  and for E.  gracilis.  The assays for riboflavin activity 
were performed in the basal medium described earlier in this paper, from which 
riboflavin was omitted. The methods of Hutner et al.  (22)  and of Hoffmann 
et et. (20) were employed for vitamin B12. The diamines to be tested were added 
after  the media  had  been sterilized.  1,2-Dimethyl-4,5-diaminobenzene  was 
1/100,000  as  active as  riboflavin for L.  casei,  and  1/1,000,000  as  active as 
vitamin Bz~ for L.  leichmanni.  For E.  gracilis it was between 1/500,000 and 
1/1,000,000 as potent as vitamin B1,. In all assays,  full growth could not be 
attained  with  the  compound  because  its  limited  solubility  restricted  the 
amount which could be added. The comparisons of activity with the two vita- 
mins  were  therefore made  only on  the  lower portion of the  standard dose- 
response curves. 
1,2-Dimethyl-4-amiuo-5-ribitylaminobenzene  3  was similarly tested. It proved 
to have no activity for vitamin Bn, but was 1/10,000 as effective as riboflavin 
for L.  casei.  This compound is one stage nearer to riboflavin than is the di- 
methyldiaminobenzene,  but  is  somewhat  more  removed  from  vitamin  Bxv 
Riboflavin activity for it has been observed previously (23). 
Effect  of Riboflavin  Plus  Vitamin  B12 on  the  Toxicity  of 1,2-Dichloro-4,5- 
diaminobenzene for Microorganisms.--The  effects of adding vitamin B12  (from 
0.001 to 0.1 7  per cc.) plus riboflavin (from 0.1  to 10 3' per cc.) on the  toxicity 
of a minimally effective dose of 1,2-dichloro-4,5-diaminobenzene were studied 
for most of the species which were susceptible to this analog.  No diminution 
in harmful action was found except with L. casei and hemolytic streptococcus 
H69D. With both of these riboflavin-requiring forms the mixture of the 2 vita- 
mins rendered the dichlorodiaminobenzene slightly less inhibitory of growth. 
The effect was observable only at levels of the latter which still permitted fair 
growth in the absence of the additional riboflavin and the B12. An amount of the 
dichloro compound which was able  to suppress growth completely could not 
thus be rendered less harmful. The data in Table V illustrate  these facts. The 
magnitude of this antagonism was such as to raise doubts about its existence 
but the effect was observed regularly. 
Excessive amounts of riboflavin (10 3" per cc. of culture medium) inhibited 
the growth of some of the species, e.g., S. aureus. These harmful concentrations 
of the vitamin enhanced rather than diminished the toxicity of the dichloro- 
diaminobenzene. This was found to be the case whether vitamin B12 was present 
or absent. 
Effect  of Replacement  of  Vitamin  BIS by  Desoxyribosides  on  the  Toxicity  of 
1,2-Dichloro-4,5-diaminobenzene  for  L.  bifldis.--Because  the  nutritional  re- 
quirement for vitamin Bx2 can be met by additions of desoxyribosides in the 
case of L.  bifldis  (21), an effort was made to find whether the replacement of 
a Samples of this substance were very kindly supplied by Dr. J. A. Aeschlimann of Hoff- 
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vitamin BI~ in the medium in this way would render this species susceptible to 
the dichlorodiaminobenzene. Vitamin B12 was therefore omitted, and desoxy- 
guanosine (10 "r per cc.) was added to the basal medium. Under these condition~ 
300 3' of the analog per cc. did not retard growth. The result was the sam~ 
when desoxyinosine was used in place of desoxyguanosine. 
The experiments were repeated with L. leichraanni strain 313. However, in 
contrast to reports in the literature (24), neither desoxyguanosine nor desoxy- 
inosine would support growth in the absence of vitamin Bu. Therefore a  trial 
with the dichlorodiamine was not possible. 
TABLE  V 
Effect  of  Riboflatqn Plus  Vitamin  B12  on  the  Growth-Retarding Action  of  1,2-Dichloro- 
4,5-diaminobenzene Dihydrochloride  for Lactobacillus casd 
Riboflavin 
'y pet' ¢6. 
0.1 
0.1 
1.1 
0.1 
0.1 
1.1 
1.1 
1.1 
Vitamin B~2  Dichlorodiaminobenzene 
dihydrochloride 
o 
0.05 
0 
0 
0 
0.05 
0.05 
0 
"y p~ ¢C. 
o 
o 
o 
lOO 
30 
lOO 
30 
lOO 
Light transmission 
~er Cent 
35 
32 
32 
48 
35 
40 
34 
47 
DISCUSSION 
The success in predicting what species would be susceptible to 1,2-dichloro- 
4,5-diaminobenzene  from  a  consideration  of  nutritional  requirements  adds 
more support to the postulate that selectively toxic substances can be realized 
in the same way. Similarly, the results harmonize with the idea that agents 
may be formed which are not counteracted by substances further up the bio- 
synthetic metabolic path  if a  metabolite is chosen which is the precursor of 
two or more of them. This latter point is still quite tenuous, and requires much 
further exploration. Several parts of the argument lack sufficient experimental 
support. In the first place, no convincing evidence was found that 1,2-dimethyl- 
4,5-diaminobenzene  actually  is  the  metabolic  precursor  of  riboflavin  and 
vitamin B12. Points in favor of its being such are (a) its undeniable occurrence 
in the two vitamins,  (b) its slight activity in replacement of each of these two 
vitamins, and (c) its ability to counteract in a competitive fashion the toxicity 
of  1,2-dichloro-4,5-diaminobenzene. Data  difficult to  reconcile with  such  a 
view are (a)  that  it is  not more active in counteracting the harmful effects 
of  the  dichloro analog,  and  (b)  that  o-phenylenediamine will  overcome the 
toxicity of the dichlorodiaminobenzene. D.  W.  WOOLLEY  23 
If the concept outlined in this paper is correct, then clearly some discrimina- 
tion must be exercised in its application to other cases. The choice of the meta- 
bolic precursor may be important, because present knowledge indicates that just 
any one will not do, even though it may be the starting point for the formation 
of two or more important constituents of living cells.  Thus, glutamic acid is 
most probably used in the synthesis of both glutamine and glutathione, and 
possibly of several more metabolites as well.  And yet, structural analogs of 
glutamic acid have not proven to be selectively harmful to those species which 
perform the syntheses of these compounds. Indiscriminate application of the 
present concept would require them to do so. 
The bases for a discriminating choice do not seem clear. Perhaps, if one wishes 
to inhibit cell division, one should select a precursor of some of those substances 
which are directly concerned in cell division, rather than in some other processes 
such  as energy transport  or  the  building  of anatomical structures.  In  any 
event,  metabolic precursors  do not appear  to be  of equal aptitude for this 
purpose. 
It is quite conceivable that the toxicity of dichlorodiaminobenzene has no 
relationship  to the biosynthesis of riboflavin and of vitamin BI~. The antago- 
nism of its effect with the  dimethyldiaminobenzene could then be viewed as 
follows: Cells possess a  mechanism for  metabolizing aromatic amines, which 
are poisonous for unknown reasons.  The dimethyldiamine is intrinsically less 
toxic  than  the  dichlorodiamine.  (This has actually proved  to  be  the  case.) 
The less toxic dimethyl compound may thus be able to exclude the more harmful 
dichloro compound and thus protect the cell. While such a view is tenable, it 
seems less likely than the other one proposed, especially in light of the correla- 
tions of toxicity with nutritional needs for two vitamins which possess  the 
dimethyldiaminobenzene structure within them. 
SUM-I~d~Y 
In a series of 26 species selected from widely differing classes, 1,2-dichloro- 
4,5-diaminobenzene was  toxic  to  those which did not exhibit a  nutritional 
need for riboflavin plus vitamin Bu. It failed to retard the growth of those 
which needed both  of these vitamins. The  compound was  conceived as an 
antimetabolite of 1,2-dimethyl-4,5-diaminobenzene. This latter, which is con- 
tained within the structures of the two vitamins, was pictured as a metabolic 
precursor of them. It was found to have very slight activity as either riboflavin 
or as vitamin BI2 for lactic acid bacteria  and  algae.  The growth-inhibiting 
action  of  the  dichlorodiaminobenzene was  overcome  competitively by  the 
dimethyldiaminobenzene, and also, to a lesser extent, by o-phenylenediamine. 
The toxicity was not influenced by additions of riboflavin plus vitamin B,2, 
except in the cases of two species,  where the influence was slight. These facts 
were considered to support  the idea that properly constructed analogs of a 
precursor of two or more essential participants in cell division may be able to 24  SELECTIVE  TOXICITY 
circumvent the counteraction which the vitamin has been found to exert on 
an  antimetabolite  of  its  precursor.  Alternate  explanations of  the  observed 
data were likewise considered. 
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